Integrative multi-omics analysis of the CALM3-FRMD6-AS2 regulatory axis in gastric cancer reveals single-cell heterogeneity and enables construction of a prognostic model
Abstract Gastric cancer exhibits high tumour heterogeneity, which hinders precision treatment. Beyond canonical calcium-signalling roles, CALM3 acts as an RNA-binding-protein, while the lncRNA FRMD6-AS2 remains poorly characterised in gastric-cancer tumour microenvironment, especially in cancer-associated fibroblasts (CAFs). This study integrated TCGA-STAD bulk transcriptome and GSE183904 single-cell datasets to characterise the CALM3-FRMD6-AS2 regulatory axis. Multiple bioinformatic algorithms predicted their potential physical interaction. Single-cell analysis identified FRMD6-AS2 as an extremely rare CAF-specific lncRNA expressed n only 0.034 % of total cells. In silico perturbation demonstrated that FRMD6-AS2 knockdown disturbed the ZEB1-CDH1 epithelial axis and activated mesenchymal programmes, and CALM3 gradient rescue could not reverse epithelial damage, indicating their parallel-synergistic non-redundant regulation of EMT. qPCR, CCK-8, flow cytometry and scratch-wound-healing assays in HGC-27 cells validated that FRMD6-AS2 knockdown suppressed proliferation, promoted apoptosis and enhanced migration, whereas CALM3 over-expression exerted opposite cellular phenotypes. A LASSO-Cox-derived prognostic risk model incorporating CALM3-FRMD6-AS2 and clinical factors showed favourable predictive performance and consistent risk trends across external GEO cohorts. Bulk-omics negative results supported the signal-dilution effect caused by this rare CAF sub-population. In conclusion, the CALM3-FRMD6-AS2 axis marks a rare malignant CAF subset and cooperatively drives EMT-related malignant progression in gastric cancer, offering novel insights for CAF heterogeneity research and stroma-targeted therapeutic strategies.
Authors
- Fan Luo (ORCID: https://orcid.org/0000-0003-0705-5576)
- Luyao Cheng
- Xuelian Shu (ORCID: https://orcid.org/0009-0001-2758-4638)
- Jing Li
- Yilin Wang
- Ren Man
Institutions
- First Hospital of Lanzhou University (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-17
- DOI
- https://doi.org/10.21203/rs.3.rs-11358791/v1
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- preprint